Navidea Biopharma (NAVB) Confirms it Won Platinum Litigation
Tweet Send to a Friend
Navidea Biopharma (NYSE: NAVB) disclosed in an SEC filing:On October 31, 2018, Judge Valerie Caproni of the United States District ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE